Cryo Cell International (CCEL) Amortization of Deferred Charges (2017 - 2026)
Cryo Cell International (CCEL) posted quarterly Amortization of Deferred Charges of $99896.0 for Q2 2026, down 44.77% year-over-year from $180868.0 in Q2 2025, and up 2.16% quarter-over-quarter from $97787.0 in Q1 2026.
Analysis
Cryo Cell International (CCEL) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Amortization of Deferred Charges for 10 consecutive years, with $99896.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Amortization of Deferred Charges fell 44.77% year-over-year to $99896.0; the TTM figure through May 2026 stood at $32391.0 (down 93.56% YoY), while the FY2025 annual figure was $20822.0, down 93.65% from the prior year.
- Amortization of Deferred Charges grew to $99896.0 in Q2 2026 per CCEL's latest filing, from $97787.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $300091.0 in Q4 2022 and bottomed at -$274832.0 in Q4 2025.
- Historically, Amortization of Deferred Charges has averaged $64858.8 across 5 years, with a median of $78298.0 in 2022.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges sank 1258.26% — and 2024, when it soared 4099.18%.
- Cryo Cell International's Amortization of Deferred Charges stood at $300091.0 in 2022, then fell by 1.87% to $294485.0 in 2023, then slumped by 69.29% to $90451.0 in 2024, then plunged by 403.85% to -$274832.0 in 2025, then jumped by 136.35% to $99896.0 in 2026.
- Business Quant data shows CCEL's Amortization of Deferred Charges at $99896.0 in Q2 2026, $97787.0 in Q1 2026, and -$274832.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn |
| 10 | Cryo Cell International | 32.55 Mn | 29.39 Mn | 6.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 5,109.00 |
| Feb 28, 2026 | 5,136.00 |
| Nov 30, 2025 | 5,165.00 |
| Aug 31, 2025 | 5,192.00 |
| May 31, 2025 | 5,219.00 |
| Feb 28, 2025 | 5,246.00 |
| Nov 30, 2024 | 5,270.00 |
| Aug 31, 2024 | 5,298.00 |
| May 31, 2024 | 5,321.00 |
| Feb 29, 2024 | 5,348.00 |
| Nov 30, 2023 | 5,372.00 |
| Aug 31, 2023 | 5,397.00 |
| May 31, 2023 | 5,418.00 |
| Feb 28, 2023 | 5,444.00 |
| Nov 30, 2022 | 5,466.00 |
| Aug 31, 2022 | 591.00 |
| May 31, 2022 | 3,388.00 |
| Feb 28, 2022 | 6,389.00 |
| Nov 30, 2021 | 9,389.00 |
| Aug 31, 2021 | 12,390.00 |